跳至主要内容
临床试验/NCT03487380
NCT03487380终止不适用

Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease

Nantes University Hospital4 个研究点 分布在 1 个国家目标入组 86 人开始时间: 2017年9月4日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
86
试验地点
4
主要终点
analysis of the taxonomic and functional composition of the microbiome

研究概览

简要总结

The objective of the study is to highlight a modification of the composition of the intestinal microbiota associated with the diagnosis of Alzheimer's disease and its most unfavorable form, Rapid Cognitive Decline (DCR). This identification could lead to diagnostic strategies based on the analysis of the intestinal microbiome, and preventive and curative treatments, based on the modulation of intestinal microbiota

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
70 Years 至 90 Years(Older Adult)
性别
All
接受健康志愿者

入选标准

  • For Alzheimer groups without DCR and Alzheimer with DCR:
  • patients between 70 and 90 years old
  • with mild to moderate Alzheimer's disease (MMSE> 15/30),
  • followed in the CMRR of the University Hospital of Nantes or Angers
  • having given their informed consent
  • For the control group (non-Alzheimer's)
  • more patients between 70 and 90 years
  • consultant for a subjective memory complaint isolated at the CMRR of Nantes or Angers University Hospital,
  • having given their informed consent

排除标准

  • Major patients under tutorship, curatorship or safeguard of justice
  • Cognitive disorders possibly related to a metabolic or psychiatric cause
  • History of prescription of antibiotic treatment in the last month
  • History of acute gastrointestinal illness in the last month
  • History of hospitalization for an acute medical pathology or for a surgical procedure in the last month

结局指标

主要结局

analysis of the taxonomic and functional composition of the microbiome

时间窗: 1 year

("shotgun sequencing"), in patients with DCR (loss of at least 3 points in the MMSE at 1 year.

次要结局

  • to determine if there is a specific modification of the composition of the intestinal microbiota of patients with Alzheimer's disease, compared to control group.(Day 0)
  • create a prognostic score of DCR based on clinical data, including the responses to the MMSE, BREF and MNA questionnaires, and taking into account the microbiota analysis(1 year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验